<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): SEPTEMBER 2, 1998
-----------------
COPLEY PHARMACEUTICAL, INC.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation or organization)
0-20126 04-2514637
(Commission File Number) (IRS Employer Identification No.)
25 JOHN ROAD
Canton, Massachusetts 02021
(Address of principal executive offices) (Zip Code)
(781) 821-6111
(Registrant's telephone number, including area code)
Page 1 of 3 Pages
<PAGE>
ITEM 5. OTHER EVENTS.
On September 2, 1998, Copley Pharmaceutical, Inc. announced that it had been
served as a nominal defendant in a shareholder derivative action against six of
its seven current Directors. The lawsuit, which was brought by Great Neck
Capital Appreciation Investment Partnership, the owner of an unspecified number
of Copley shares, is pending in Norfolk County, Massachusetts Superior Court.
The complaint's allegations include alleged breach of fiduciary duty and alleged
waste of corporate assets and it seeks unspecified damages.
Page 2 of 3 Pages
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
September 4, 1998 COPLEY PHARMACEUTICAL, INC.
/s/ Daniel M. P. Caron
----------------------
Daniel M. P. Caron
Vice President Finance, Chief Financial
Officer and Treasurer
(Principal Financial Officer)
Page 3 of 3 Pages
